ALNY vs VRAR · P/E 76, rev $1.29B vs rev $10.5M
Alnylam Pharmaceuticals Inc (ALNY) versus Glimpse Group Inc (VRAR) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Glimpse Group Inc (VRAR) is a software - infrastructure company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported VRAR revenue for 2025-06-30 was $10.5M. Net income was -$2.6M. Revenue was up 19.6% from 2024-06-30 to 2025-06-30. VRAR currently screens at market cap $31.0M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. VRAR currently screens at market cap $31.0M.
Not investment advice. Open the ALNY and VRAR stock pages for the full models.
Not investment advice.